{"result": "(\"entity\"<|>CARDIOVASCULAR DISEASE<|>PERSON<|>Cardiovascular disease refers to a range of conditions affecting the heart and blood vessels, often associated with diabetes and other health risks.)\n##\n(\"entity\"<|>HEART ATTACK<|>EVENT<|>A heart attack, also known as a myocardial infarction, occurs when blood flow to the heart is blocked, often leading to serious health complications.)\n##\n(\"entity\"<|>STROKE<|>EVENT<|>A stroke is a medical emergency that occurs when the blood supply to the brain is interrupted, which can be a risk for patients with diabetes.)\n##\n(\"entity\"<|>HYPERTENSION<|>PERSON<|>Hypertension, or high blood pressure, is a common condition that can lead to serious health issues, including heart disease and stroke, particularly in individuals with diabetes.)\n##\n(\"entity\"<|>STATINS<|>ORGANIZATION<|>Statins are a class of drugs used to lower cholesterol levels in the blood, which can help reduce the risk of cardiovascular disease in patients with diabetes.)\n##\n(\"relationship\"<|>DIABETES<|>CARDIOVASCULAR DISEASE<|>Diabetes significantly increases the risk of developing cardiovascular disease due to its effects on blood vessels and heart health<|>9)\n##\n(\"relationship\"<|>DIABETES<|>HYPERTENSION<|>Individuals with diabetes often experience hypertension, which is a common comorbidity that increases health risks<|>8)\n##\n(\"relationship\"<|>CARDIOVASCULAR DISEASE<|>HEART ATTACK<|>Cardiovascular disease is a major risk factor for heart attacks, particularly in patients with diabetes<|>9)\n##\n(\"relationship\"<|>CARDIOVASCULAR DISEASE<|>STROKE<|>Cardiovascular disease increases the likelihood of experiencing a stroke, especially in individuals with diabetes<|>9)\n##\n(\"relationship\"<|>DIABETES<|>STATINS<|>Statins are often prescribed to patients with diabetes to manage cholesterol levels and reduce cardiovascular risks<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ó en ambos grupos.\n         culares que con mayor frecuencia se observan como presentación inicial.\n         Los pacientes con DM2 tienen una mayor prevalencia de dislipidemia, lo que contribuye al                           COMENTARIO\n         mayor riesgo de enfermedad cardiovascular. Multitud de ensayos clínicos han demostrado los                         El estudio EDIC constituye el seguimiento a largo plazo de la mayor parte de los pacientes\n         beneficios del tratamiento con estatinas en los resultados cardiovasculares, tanto en sujetos                      con DM1 incluidos inicialmente en el estudio DCCT (1.394 individuos, 97% de la cohorte ini-\n         con enfermedad coronaria como en aquellos que no la presentan. En pacientes con diabetes,                          cial). Al no existir intervención, el control metabólico conseguido (HbA1c del 7% en el grupo\n         las estatinas han demostrado beneficios tanto en la prevención primaria como en la preven-                         de control intensivo y del 9% en el grupo control a los 6,5 años de media) fue igualándose\n         ción secundaria de la enfermedad cardiovascular y de la mortalidad asociada a esta.                                en ambas ramas hasta una HbA1c del 8%, a pesar de lo cual se mantuvieron los resultados\n                                                                                                                            iniciales    positivos a lo largo del tiempo (seguimiento a 20 años en                       el estudio EDIC). Así,\n                                                                                                                            en el grupo de tratamiento intensivo se observó una menor incidencia y progresión de la\n                                                                                                                            retinopatía diabética (descenso del 53-56%), de la micro/macroalbuminuria incidente (re-\n                                                                                                                            ducciones del 59/84%), una mejoría en la tasa                    de filtrado glomerular (50%) y una menor\n                                                                                                                            incidencia de hipertensión arterial (20%).\n\n\n\n114                                                                                                                                                                                                                                                      115\n---\n                                                                                                                                                                                                                                                 DIABETES                           2\n\n\n\n               El control intensivo (durante 6,5 años) influyó en los resultados cardiovasculares en el se-                                            Numerosos estudios han demostrado que la ingesta moderada de alcohol se asocia con\n               guimiento posterior (a los 20 años de haber finalizado la intervención), tanto en la arterioes-                                         una menor incidencia de enfermedades cardíacas y mortalidad cardiovascular.\n               clerosis subclínica (menor             grosor íntima-media carotídea, menor calcificación                       coronaria,              Referencias:\n               etc.) como en los eventos cardiovasculares (infarto agudo de miocardio, accidente vascular                                              • Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med.\n                                                                                                                                                         2004;38:613-9.\n               cerebral y muerte cardíaca).                                                                                                            • Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G. Cardiovascular and overall mortality risk in relation to alcohol\n                                                                                                                                                         consumption in patients with cardiovascular disease. Circulation. 2010;121:1951-9.\n               En cuanto a la mortalidad, en este período de tiempo ocurrieron 107 defunciones, de las que 64 co-                                      • Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. Consensus statement by the American Asso-\n                                                                                                                                                         ciation of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management\n               rrespondieron al grupo convencional y 43, al grupo de tratamiento intensivo, siendo la diferencia                                         algorithm - 2019 executive summary. Endocr Pract. 2019;25(1):69-100.\n               absoluta de riesgo de -109 por 100.000 pacientes/año (IC 95% -218 a -1) con menor mortalidad\n               por cualquier causa en el grupo intensivo, con un hazard ratio (HR) de 0,67 (IC 95% 0,46-0,99,\n               p = 0,045). Concluyen que tras 27 años de seguimiento de pacientes con DM1, después de una                                          56  Según los Standards of Medical Care de la ADA 2019, en pacientes de 40 a 75 años,\n               terapia intensiva durante 6,5 años, se constató una modesta disminución de la mortalidad por                                            con diabetes y sin factores adicionales de riesgo cardiovascular, debe considerarse\n               cualquier causa del grupo inicialmente intensivo respecto al grupo de tratamiento convencional.                                         el uso de:\n               Aunque la mortalidad atribuida a hipoglucemia fue mayor en el grupo de tratamiento inten-                                               A. Medidas sobre el estilo de vida y estatinas de intensidad moderada.\n               sivo (11,3 %) comparado con el grupo convencional (6,1%), el beneficio de menor mortali-\n               dad en el grupo de tratamiento intensivo se mantuvo.                                                                                    B. Medidas sobre el estilo de vida y estatinas de alta intensidad.\n                                                                                                                                                       C. Medidas sobre el estilo de vida únicamente.\n               Referencias:\n               • Gubitosi-Klug RA; DCCT/EDIC Research\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>EDIC<|>EVENT<|>The EDIC study is a long-term follow-up of patients with diabetes, particularly those who were part of the DCCT study, focusing on cardiovascular outcomes over 20 years.)\n##\n(\"entity\"<|>DCCT<|>EVENT<|>The DCCT study was a clinical trial involving 1,394 individuals with diabetes, aimed at understanding the effects of intensive treatment on diabetes outcomes.)\n##\n(\"entity\"<|>DIABETES<|>PERSON<|>Diabetes is a chronic health condition that affects how the body processes blood sugar (glucose) and is associated with various health risks, including cardiovascular disease.)\n##\n(\"entity\"<|>AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS<|>ORGANIZATION<|>The American Association of Clinical Endocrinologists is a professional organization that provides guidelines and consensus statements on diabetes management and related health issues.)\n##\n(\"entity\"<|>AMERICAN COLLEGE OF ENDOCRINOLOGY<|>ORGANIZATION<|>The American College of Endocrinology is a professional organization focused on the study and treatment of endocrine disorders, including diabetes.)\n##\n(\"relationship\"<|>EDIC<|>DCCT<|>The EDIC study is a follow-up to the DCCT study, tracking long-term outcomes of the same patient cohort<|>8)\n##\n(\"relationship\"<|>DIABETES<|>EDIC<|>The EDIC study focuses on patients with diabetes, examining the long-term effects of treatment on their health<|>7)\n##\n(\"relationship\"<|>AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS<|>AMERICAN COLLEGE OF ENDOCRINOLOGY<|>Both organizations provide guidelines and consensus statements on diabetes management and collaborate on clinical practices<|>6)\n<|COMPLETE|>"}]}